anmelden
FTSE All-Share
5.735,46
PKT
+15,93
PKT
+0,28
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu FTSE All-Share-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 29.01.21 | Prudential buy | Deutsche Bank AG | |
| 29.01.21 | Diageo buy | Deutsche Bank AG | |
| 29.01.21 | Diageo buy | Jefferies & Company Inc. | |
| 28.01.21 | Diageo Sector Perform | RBC Capital Markets | |
| 28.01.21 | Lloyds Banking Group Sell | Goldman Sachs Group Inc. | |
| 28.01.21 | Diageo buy | Goldman Sachs Group Inc. | |
| 28.01.21 | Diageo Underweight | JP Morgan Chase & Co. | |
| 28.01.21 | Diageo buy | UBS AG | |
| 28.01.21 | Diageo overweight | Barclays Capital | |
| 28.01.21 | Diageo Outperform | Bernstein Research | |
| 28.01.21 | Diageo buy | Jefferies & Company Inc. | |
| 28.01.21 | Diageo Sector Perform | RBC Capital Markets | |
| 28.01.21 | Barclays buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 27.01.21 | Prudential Sector Perform | RBC Capital Markets | |
| 27.01.21 | Shell (ex Royal Dutch Shell) Outperform | RBC Capital Markets | |
| 27.01.21 | GSK buy | Goldman Sachs Group Inc. | |
| 27.01.21 | Rio Tinto Neutral | Goldman Sachs Group Inc. | |
| 27.01.21 | Barclays Neutral | Goldman Sachs Group Inc. | |
| 27.01.21 | Diageo Outperform | Bernstein Research | |
| 27.01.21 | GSK Neutral | JP Morgan Chase & Co. | |
| 27.01.21 | Shell (ex Royal Dutch Shell) overweight | JP Morgan Chase & Co. | |
| 27.01.21 | Shell (ex Royal Dutch Shell) overweight | JP Morgan Chase & Co. | |
| 26.01.21 | AstraZeneca Neutral | UBS AG | |
| 26.01.21 | GSK Hold | Deutsche Bank AG | |
| 26.01.21 | GSK buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 25.01.21 | Rio Tinto Sector Perform | RBC Capital Markets | |
| 25.01.21 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 25.01.21 | HSBC Underweight | JP Morgan Chase & Co. | |
| 22.01.21 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 22.01.21 | National Grid Neutral | UBS AG | |
| 22.01.21 | AstraZeneca overweight | Barclays Capital | |
| 21.01.21 | Prudential buy | UBS AG | |
| 21.01.21 | Shell (ex Royal Dutch Shell) buy | Jefferies & Company Inc. | |
| 21.01.21 | BP Hold | Jefferies & Company Inc. | |
| 20.01.21 | GSK buy | Goldman Sachs Group Inc. | |
| 20.01.21 | Diageo overweight | Barclays Capital | |
| 20.01.21 | GSK Neutral | UBS AG | |
| 20.01.21 | Rio Tinto Hold | Deutsche Bank AG | |
| 20.01.21 | AstraZeneca Outperform | Credit Suisse Group | |
| 20.01.21 | GSK Underperform | Credit Suisse Group |